Teva Pharmaceutical Ind Ltd. – Investors and Politicians Who Own It

TEVA

Investors who own it

11 tracked investors, $1.1B in shares, each from their latest 13F.

InvestorValueShare of portfolio
David RosenRubric Capital Management, Q2 2026
$527.7M4.84%
Anand ParekhAlyeska Investment Group, Q2 2026
$212M0.55%
Larry RobbinsGlenview Capital Management, Q2 2026
$172.1M3.13%
$81.5M0.05%
Ray DalioBridgewater Associates, Q2 2026
$44.9M0.18%
Stanley DruckenmillerDuquesne Family Office, Q2 2026
$21.2M0.41%
Daniel SchneebergerADAR1 Capital Management, Q2 2026
$9.4M0.43%
Cathie WoodARK Investment Management, Q2 2026
$2.3M0.02%
Mario GabelliGAMCO Investors, Q2 2026
$2.2M0.02%
$1.4M0.01%
Barry RitholtzRitholtz Wealth Management, Q2 2026
$694.2K0.01%

Politicians who own it

Estimated from annual disclosures and trades; values are rough estimates.

PoliticianEst. valueShare of portfolio
Alan ArmstrongR-OK · Senate
$11.1K0.22%
InvestorActionShares now
Zach SchreiberAdded +12%15,131,488
National Pension Service (Korea)Reduced −46%1,655,392
Larry RobbinsAdded +75%14,778,641
David GreenspanAdded +14%9,655,998
Anand ParekhReduced −11%3,225,613
Stanley DruckenmillerAdded +65%14,879,750
David RosenAdded +50%25,550,000
Andreas HalvorsenAdded +56%10,125,478
Daniel SchneebergerAdded +257%523,767
Zach SchreiberCallAdded +47%3,672,100
Mario GabelliReduced −12%93,200
Cathie WoodReduced −10%90,253
Barry RitholtzReduced −38%21,791
Bill MillerSold out0
Ray DalioSold out0
Lee AinslieAdded +114%30,292

Politicians trading it

Latest Congress trades disclosed under the STOCK Act; amounts are ranges.

PoliticianActionTraded
Alan ArmstrongR-OK · Senate
Bought$1K–$15KMar 30, 2026disclosed Jul 21, 2026